Thyrocare Technologies Ltd

Thyrocare Technologies Dividend

Thyrocare Technologies recommended a final dividend of Rs. 7.00 per share for FY2025-26. Total annual dividend reached Rs. 9.33 per share following shareholder approval.

Thyrocare Technologies Results Update

Thyrocare Technologies reported FY26 consolidated revenue of ₹829.04 Crore, up 21% YoY. Net profit surged 81% to ₹162.85 Crore, driven by pathology segment growth.

Value

₹829.0 Cr

Thyrocare Technologies Earnings Call: Key Takeaways

Thyrocare reports strong performance for Q4FY26 and FY26 with significant YoY growth in PAT and EBITDA driven by network expansion and operational efficiencies.

Thyrocare Technologies Earnings Call: Key Takeaways

Thyrocare reports robust growth for Q4FY26 and FY26, driven by franchise expansion and new specialty launches like Genomics and Allergy testing.

Thyrocare Technologies Q4 FY26 Results: Net Profit ₹48.7 Cr, Up 125.5% YoY

Thyrocare Technologies Ltd reported revenue from operations of ₹223.9 Cr (+19.6% YoY) and net profit of ₹48.7 Cr (+125.5% YoY) for Q4 FY26.

Key figure

Net profit ₹48.7 Cr · +125.5% YoY

Thyrocare Technologies Financial Results

Thyrocare Technologies reported FY26 consolidated revenue of ₹829.04 Crore and PAT of ₹162.85 Crore. The Board recommended a final dividend of ₹7.00 per share and approved the appointment of Price Waterhouse LLP as Statutory Auditors. The company also announced a ₹5.50 Crore investment in its wholly-owned subsidiary, Think Health Diagnostics.

Thyrocare Technologies Other Announcement

Thyrocare Technologies Ltd has cancelled its Earnings Conference Call originally scheduled for May 07, 2026, at 5:30 P.M. (IST) due to unforeseen circumstances. The call was intended to discuss the company's audited financial results for the quarter and year ended March 31, 2026. A revised schedule will be announced later.

Thyrocare Technologies Board Meeting Date

Thyrocare Technologies Limited has scheduled a Board Meeting for May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 9, 2026.

Thyrocare Technologies Board Meeting Date

Thyrocare Technologies Ltd will hold a Board meeting on May 07, 2026, to approve audited financial results for FY26 and recommend a final dividend. The company's trading window closed on April 01, 2026, and will reopen 48 hours after the results declaration.

Thyrocare Technologies Q3 FY26 Results: Net Profit ₹28.1 Cr, Up 48.7% YoY

Thyrocare Technologies Ltd reported net profit of ₹28.1 Cr (+48.7% YoY) for Q3 FY26.

Key figure

Net profit ₹28.1 Cr · +48.7% YoY